Back to Agenda
S8 - Global Regulatory Trends and Standardization Strategies for Next-Generation Alternative Technologies
Session Chair(s)
In-sook Park, PhD
Former Director General, Korean Regulatory Science Center, Korea, Republic of
Sang Aeh Park
Director, MFDS, Korea, Republic of
Speaker(s)
Beyond 3Rs: Transitioning to Human-Centric Toxicity Platforms through Regulatory Science Integration of NAMs
Joohwan Kim
Depury Director, Nonclinical Resource Research Division, NIFDS, MFDS, Korea, Republic of
Validation and Qualification of NAMs towards Regulatory Acceptance and Widespread Adoption
Danilo Tagle, PhD
Director, Office of Special Initiative, National Center For Advancing Translational Sciences (NCATS), NIH, United States
NAMs: Regulatory Science Alternatives
Dean Smith, PhD
Advisor to the Director & Sr. Evaluator, Health Canada, Centre for Vaccines, Clinical Trials & Biostatistics, Canada
Global Trends in NAMs and Industry Perspectives on Key Challenges
Ran Noh, MS
Team Manager, Korea Biomedicine Industry Association (KoBIA), Korea, Republic of
Jaeok Kim
Director, Biologics Division, NIFDS, MFDS, Korea, Republic of
Have an account?